REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
14/04/2025
Voltar para busca
Dado oficial do USPTO
BIONDIS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
BIONDIS
ST13
US500000088585565Classe
5, 10, 35, 42
Pedido
88585565
Registro
6032608
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
15/04/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10, 35, 42
Data de depósito
20/08/2019
Data de registro
14/04/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
14/04/2020
Última transação
15/04/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
16
Localização do titular
6545 CM NIJMEGEN, NL
Examinador
MCCAULEY, BRENDAN
Unidade examinadora
M50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
BYONDIS B.V.
Synthon Biopharmaceuticals B.V
Representantes
E. Anthony Figg ROTHWELL FIGG ERNST & MANBECK PC
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Biopharmaceutical preparationssubstances and compositionsantibacterial substances for medical purposesmedical diagnostic reagents in the nature of antibody-drug conjugatesimmuno-oncology compounds in the nature of medicinal preparations for the treatment of infectious diseases and for use in oncologycompounds for auto-immune diseasespharmaceutical preparations for the treatment of immune system related diseases and disorders; biopharmaceutical active substancesdiagnostic agentspreparations and substances for medical purposes in the nature of antibody-drug conjugatesimmuno-oncology compoundspharmaceutical preparations and substances for the treatment of oncological related diseases and disorderscompounds for auto-immune diseasespharmaceutical preparations for the treatment of immune system related diseases and disorders; biological and biochemical drug and cultures for medical usebiological preparations for the treatment of cancercultures of microorganisms for medical usebiological tissue cultures for medical purposes; biopharmaceutical active substancesnutritive substances for microorganism cultures; biopharmaceutical components and ingredientsplant and herb extracts sold as components of medicated cosmetics; orthopedic articlesbone repair paste for use in orthopedic surgery; all of the above excluding for the treatment of neuromuscular diseases and disorders
Classe 10
Surgical and medical devicesapparatus and instrumentssurgical instruments and apparatussurgical devices and instrumentssurgical apparatus and instrumentsmedical instruments for cutting tissuemedical instrument for performing biopsiesmedical fluid injectorsinjection device for pharmaceuticalssyringes for medical purposesdisposable syringes for medical purposes; orthopedic articlesorthopedic walkersorthopedic supportsorthopedic braces and orthopedic cushions; injection apparatus for medical purposesinjection needles and injection instruments with needles
Classe 35
Providing office functions relating to the registration of pharmaceutical preparations and components and pharmaceutical drugs; providing office functions relating to obtaining pharmaceutical registrations and compiling pharmaceutical registration files; business mediation of commercial transactions for othersmediation of contracts for the purchase and sale of productsmediation of agreements all in the field of the purchasesale and licensing of pharmaceutical registrations and pharmaceutical registration files
Classe 42
Scientific and technological services and research relating theretoscientific researchanalysis and testing in the fields of antibody-drug conjugatesimmuno-oncology compounds and compounds for auto-immune diseases and scientific research related thereto; scientific and technological services relating to obtaining pharmaceutical registrations and compiling pharmaceutical registration filesscientific research in the field of pharmaceuticals for pharmaceutical registration purposes; pharmaceutical research services and pharmaceutical research consultancy services; biomedical research services and biomedical research consultancy; medical research and medical research consultancy; scientific laboratory services in the fields of chemistry and biologyantibody-drug conjugatesimmuno-oncology compounds and compounds for auto-immune diseases; scientific laboratory services; product development of pharmaceutical products and ingredients for pharmaceuticals; providing information relating to medical and scientific research in the field of pharmaceutical preparations; providing medical and scientific research information regarding the results of clinical trials for pharmaceutical preparations; quality control of products for others to determine conformity with certification standards; laboratory researchscientific and medical research; laboratory analysis in the field of chemistry and biology as related to pharmaceuticals; product research for the pharmaceutical industry; design of pharmaceuticals for the pharmaceutical industry; product research and development for others; drug discovery services; testing in the context of quality controlmaterial testing and product testing; conducting clinical trials for others in the field of pharmaceutical preparations; quality control for others in the field of pharmaceutical preparations; providing information and data relating product research and developments in the pharmaceuticalbiopharmaceutical and medical fields
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
21/11/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
21/11/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
21/11/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
21/11/2022
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
13/05/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
14/04/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/01/2020
PUBO
PUBLISHED FOR OPPOSITION
28/01/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/01/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
19/12/2019
DOCK
ASSIGNED TO EXAMINER
12/12/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
11/12/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/12/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
11/12/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/12/2019
DOCK
ASSIGNED TO EXAMINER
11/12/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/12/2019
GNRT
NON-FINAL ACTION E-MAILED
09/12/2019
CNRT
NON-FINAL ACTION WRITTEN
09/12/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/12/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/12/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/11/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
20/11/2019
GNRT
NON-FINAL ACTION E-MAILED
20/11/2019
CNRT
NON-FINAL ACTION WRITTEN
20/11/2019
DOCK
ASSIGNED TO EXAMINER
19/11/2019
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
05/11/2019
ALIE
ASSIGNED TO LIE
31/10/2019
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
25/10/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/09/2019
NWAP
NEW APPLICATION ENTERED
23/08/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BIONDIS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.